Cargando…

Minimal invasive surgery in treatment of liver metastases from colorectal carcinomas: case studies and survival rates

BACKGROUND: Liver represents the main organ subject to metastases from colorectal tumors. Resections of liver metastases from colorectal cancer have a well-considered therapeutic role underlined by survival of 5 years by approximately 50-60% of surgical cases as is deduced from an analysis of the mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Loffredo, Domenico, Marvaso, Alberto, Ceraso, Sandro, Cinelli, Nicola Angelo, Rocca, Aldo, Vitale, Mario, Rossi, Michele, Genovese, Eugenio Annibale, Amato, Bruno, Cinelli, Mariapia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850987/
https://www.ncbi.nlm.nih.gov/pubmed/24267179
http://dx.doi.org/10.1186/1471-2482-13-S2-S45
_version_ 1782294205145546752
author Loffredo, Domenico
Marvaso, Alberto
Ceraso, Sandro
Cinelli, Nicola Angelo
Rocca, Aldo
Vitale, Mario
Rossi, Michele
Genovese, Eugenio Annibale
Amato, Bruno
Cinelli, Mariapia
author_facet Loffredo, Domenico
Marvaso, Alberto
Ceraso, Sandro
Cinelli, Nicola Angelo
Rocca, Aldo
Vitale, Mario
Rossi, Michele
Genovese, Eugenio Annibale
Amato, Bruno
Cinelli, Mariapia
author_sort Loffredo, Domenico
collection PubMed
description BACKGROUND: Liver represents the main organ subject to metastases from colorectal tumors. Resections of liver metastases from colorectal cancer have a well-considered therapeutic role underlined by survival of 5 years by approximately 50-60% of surgical cases as is deduced from an analysis of the most recent literature. The objective of surgery is to eradicate the metastases present and obtain a margin free from neoplastic impact of amplitude of approximately 1 cm with residual liver quantity at the end of the intervention that allows the patient to survive. Currently the dimensions and the number of colorectal liver metastases (CRLM) do not limit the hepatectomy. Purpose of this work is to evaluate the survival, according to our case studies of patients treated only with the wedge resection (atypical resection) approximately 1 cm from the margins of metastases. METHODS: In "A. Rizzoli" Lacco Ameno Hospital (Ischia), from 2005 to 2010, 12 liver resections were performed for metastases from colorectal carcinoma with atypical resection. Synchronous surgical treatment with resection of the colorectal carcinoma and metastases was performed in 6 patients, 2 female and 4 male (Group 1). Surgical liver metastasectomy post-colectomy was performed on 6 patients, 3 female and 3 male (Group 2). RESULTS: No patient was treated with chemotherapy. The mortality rate of intraoperative and perioperative infection was in both cases of 0%. Survival:11 patients treated surgically from 2005-2010 with synchronous surgery resection (Group 1) and liver metastasectomy (Group 2) are currently living. One 77-years-old patient died three years after surgery for BPCO. CONCLUSIONS: This result was able to be obtained due to the wedge resection technique routinely used in our Hospital, associated with the indispensable use of intraoperatory ultrasound (IOUS). Significant differences between the synchronous and non-synchronous intervention emerged only regarding the number of days of hospital stay, higher in the first case.
format Online
Article
Text
id pubmed-3850987
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38509872013-12-13 Minimal invasive surgery in treatment of liver metastases from colorectal carcinomas: case studies and survival rates Loffredo, Domenico Marvaso, Alberto Ceraso, Sandro Cinelli, Nicola Angelo Rocca, Aldo Vitale, Mario Rossi, Michele Genovese, Eugenio Annibale Amato, Bruno Cinelli, Mariapia BMC Surg Research Article BACKGROUND: Liver represents the main organ subject to metastases from colorectal tumors. Resections of liver metastases from colorectal cancer have a well-considered therapeutic role underlined by survival of 5 years by approximately 50-60% of surgical cases as is deduced from an analysis of the most recent literature. The objective of surgery is to eradicate the metastases present and obtain a margin free from neoplastic impact of amplitude of approximately 1 cm with residual liver quantity at the end of the intervention that allows the patient to survive. Currently the dimensions and the number of colorectal liver metastases (CRLM) do not limit the hepatectomy. Purpose of this work is to evaluate the survival, according to our case studies of patients treated only with the wedge resection (atypical resection) approximately 1 cm from the margins of metastases. METHODS: In "A. Rizzoli" Lacco Ameno Hospital (Ischia), from 2005 to 2010, 12 liver resections were performed for metastases from colorectal carcinoma with atypical resection. Synchronous surgical treatment with resection of the colorectal carcinoma and metastases was performed in 6 patients, 2 female and 4 male (Group 1). Surgical liver metastasectomy post-colectomy was performed on 6 patients, 3 female and 3 male (Group 2). RESULTS: No patient was treated with chemotherapy. The mortality rate of intraoperative and perioperative infection was in both cases of 0%. Survival:11 patients treated surgically from 2005-2010 with synchronous surgery resection (Group 1) and liver metastasectomy (Group 2) are currently living. One 77-years-old patient died three years after surgery for BPCO. CONCLUSIONS: This result was able to be obtained due to the wedge resection technique routinely used in our Hospital, associated with the indispensable use of intraoperatory ultrasound (IOUS). Significant differences between the synchronous and non-synchronous intervention emerged only regarding the number of days of hospital stay, higher in the first case. BioMed Central 2013-10-08 /pmc/articles/PMC3850987/ /pubmed/24267179 http://dx.doi.org/10.1186/1471-2482-13-S2-S45 Text en Copyright © 2013 Loffredo et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Loffredo, Domenico
Marvaso, Alberto
Ceraso, Sandro
Cinelli, Nicola Angelo
Rocca, Aldo
Vitale, Mario
Rossi, Michele
Genovese, Eugenio Annibale
Amato, Bruno
Cinelli, Mariapia
Minimal invasive surgery in treatment of liver metastases from colorectal carcinomas: case studies and survival rates
title Minimal invasive surgery in treatment of liver metastases from colorectal carcinomas: case studies and survival rates
title_full Minimal invasive surgery in treatment of liver metastases from colorectal carcinomas: case studies and survival rates
title_fullStr Minimal invasive surgery in treatment of liver metastases from colorectal carcinomas: case studies and survival rates
title_full_unstemmed Minimal invasive surgery in treatment of liver metastases from colorectal carcinomas: case studies and survival rates
title_short Minimal invasive surgery in treatment of liver metastases from colorectal carcinomas: case studies and survival rates
title_sort minimal invasive surgery in treatment of liver metastases from colorectal carcinomas: case studies and survival rates
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850987/
https://www.ncbi.nlm.nih.gov/pubmed/24267179
http://dx.doi.org/10.1186/1471-2482-13-S2-S45
work_keys_str_mv AT loffredodomenico minimalinvasivesurgeryintreatmentoflivermetastasesfromcolorectalcarcinomascasestudiesandsurvivalrates
AT marvasoalberto minimalinvasivesurgeryintreatmentoflivermetastasesfromcolorectalcarcinomascasestudiesandsurvivalrates
AT cerasosandro minimalinvasivesurgeryintreatmentoflivermetastasesfromcolorectalcarcinomascasestudiesandsurvivalrates
AT cinellinicolaangelo minimalinvasivesurgeryintreatmentoflivermetastasesfromcolorectalcarcinomascasestudiesandsurvivalrates
AT roccaaldo minimalinvasivesurgeryintreatmentoflivermetastasesfromcolorectalcarcinomascasestudiesandsurvivalrates
AT vitalemario minimalinvasivesurgeryintreatmentoflivermetastasesfromcolorectalcarcinomascasestudiesandsurvivalrates
AT rossimichele minimalinvasivesurgeryintreatmentoflivermetastasesfromcolorectalcarcinomascasestudiesandsurvivalrates
AT genoveseeugenioannibale minimalinvasivesurgeryintreatmentoflivermetastasesfromcolorectalcarcinomascasestudiesandsurvivalrates
AT amatobruno minimalinvasivesurgeryintreatmentoflivermetastasesfromcolorectalcarcinomascasestudiesandsurvivalrates
AT cinellimariapia minimalinvasivesurgeryintreatmentoflivermetastasesfromcolorectalcarcinomascasestudiesandsurvivalrates